Scott B. Czerwonka

Scott B. Czerwonka is a Delaware-based attorney whose patent litigation practice, primarily as local counsel, has involved the biotechnology and pharmaceutical sectors. His tracked appearances demonstrate experience working on both the plaintiff and defendant sides in these complex technology areas, with one plaintiff-side and one defendant-side engagement in patent infringement matters.

Currently a member of Wilks Law, Mr. Czerwonka has handled notable patent disputes in the U.S. District Court for the District of Delaware. He served as local counsel for plaintiffs Genzyme Corporation and Aventis Inc. in Genzyme Corporation v. Novartis Gene Therapies, Inc., a case involving six patents related to recombinant adeno-associated virus (AAV) vectors central to a gene therapy product. This high-stakes litigation ultimately concluded with a dismissal with prejudice by joint stipulation, with each party bearing its own costs. Additionally, he represented Genzyme Corporation as plaintiff's counsel in Genzyme Corporation v. Sarepta Therapeutics, Inc. et al. and represented Sarepta Therapeutics, Inc. as local counsel in Sarepta Therapeutics, Inc. v. Genzyme Corp. He also represented Regeneron Pharmaceuticals, Inc. as plaintiff in Regeneron Pharmaceuticals, Inc. v. Amgen Inc.

While his specific patent litigation roles have been as local counsel, Mr. Czerwonka's broader practice at Wilks Law focuses on corporate and commercial litigation in Delaware's state and federal courts, encompassing corporate governance disputes, and litigation related to mergers and acquisitions. This includes handling matters involving biotechnology companies and technology license agreements. There is no verifiable information indicating his regular appearance in PTAB or IPR proceedings.

Mr. Czerwonka earned his J.D., cum laude, from Penn State Dickinson School of Law in 2006, and his B.A., cum laude, from Elizabethtown College in 2000. He is admitted to practice in Delaware, holding Bar No. 4844. Prior to joining Wilks Law (formerly Wilks, Lukoff & Bracegirdle), his experience included practicing with DLA Piper LLP (US) and Potter, Anderson & Corroon, LLP.